. 2018 Oct-Dec;39(4):213–219. doi: 10.4103/ayu.AYU_147_18

Table 2.

Assessment of effect of therapy in group-SCL (sclerotherapy): (n=25)

Symptom	Time period	Mean		Mean diff.	% Relief	Z	W	SD	SE	P	Significance

		BT	AT
Bleeding per rectum	7^th day	2	0.68	1.32	66	-4.14	-231	0.74	0.14	<0.001	HS
	14^th day	2	0.52	1.48	74	-4-50	-325	0.50	0.10	<0.001	HS
	21st day	2	0.00	2.00	100	-5.00	-325	0.00	0.00	<0.001	HS
	28^th day	2	0.00	2.00	100	-5.00	-325	0.00	0.00	<0.001	HS
Painful defecation	7^th day	1	0.68	0.32	32	-2.00	-68	0.74	0.14	<0.008	S
	14^th day	1	0.52	0.48	48	-3.46	-78	0.50	0.10	<0.001	HS
	21st day	1	0.16	0.84	84	-4.58	-231	0.37	0.07	<0.001	HS
	28^th day	1	0.08	0.92	92	-4.79	-276	0.27	0.05	<0.001	HS
Prolapse of piles	7^th day	2	1.36	0.64	32	-4.00	-136	0.48	0.09	<0.001	HS
	14^th day	2	0.84	1.16	58	-4.71	-325	0.37	0.07	<0.001	HS
	21st day	2	0.68	1.32	66	-4.56	-325	0.47	0.09	<0.001	HS
	28^th day	2	0.16	1.84	92	-4.71	-325	0.37	0.07	<0.001	HS
Discharge per rectum	7^th day	0.8	0.16	0.64	80	-3.17	-78	0.37	0.07	<0.001	HS
	14^th day	0.8	0.00	0.8	100	-3.17	-78	0.00	0.00	<0.001	HS
	21st day	0.8	0.00	0.8	100	-3.17	-78	0.00	0.00	<0.001	HS
	28^th day	0.8	0.00	0.8	100	-3.17	-78	0.00	0.00	<0.001	HS
Size of piles	7^th day	2	1.64	0.36	18	-3.00	-45	0.48	0.09	<0.004	S
	14^th day	2	1.16	0.84	42	-4.58	-231	0.37	0.07	<0.001	HS
	21^st day	2	0.68	1.32	66	-4.56	-325	0.47	0.09	<0.001	HS
	28^th day	2	0.12	1.88	94	-4.77	-325	0.33	0.06	<0.001	HS

BT: Before Treatment, AT: After Treatment, Z: Z-test W: Wilcoxon signed rank test, SD: Standard Deviation, SE: Standard Error, P: Probability, HS: Highly Significant, S: Significant